Collaborative study for the calibration of a replacement International Standard for tetanus toxoid for use in flocculation test.


Journal

Biologicals : journal of the International Association of Biological Standardization
ISSN: 1095-8320
Titre abrégé: Biologicals
Pays: England
ID NLM: 9004494

Informations de publication

Date de publication:
Nov 2023
Historique:
received: 12 01 2023
revised: 20 07 2023
accepted: 22 08 2023
medline: 4 12 2023
pubmed: 2 9 2023
entrez: 1 9 2023
Statut: ppublish

Résumé

Here we report the results of a study to establish a replacement WHO International Standard (IS) for tetanus toxoid for use in flocculation test. The standard was calibrated in flocculation units (Lf) against the 2nd IS using the Ramon flocculation method. At its 70th meeting in October 2019, WHO ECBS established the material (coded 16/302) as the 3rd WHO IS, with an assigned value of 970 Lf/ampoule from the results of seventeen laboratories across ten different countries. The study also provided an opportunity to assess the use of alternative methods for measuring Lf. Participants were asked to use an in-house Enzyme Linked Immunosorbent Assay (ELISA) developed at NIBSC, or other suitable in-house methods, to determine ELISA-specific Lf values (Lf-eq units are specific only for pre-calibration of antitoxin in the flocculation test) of 16/302 to compare to those of the flocculation test. Nine laboratories participated by performing the NIBSC ELISA, one laboratory performed flocculation by laser light-scattering following an in-house protocol, and three laboratories performed ELISA following in-house protocols. The results intimate that these alternative methods could be useful for monitoring consistency of production at different stages of vaccine manufacturing.

Identifiants

pubmed: 37657313
pii: S1045-1056(23)00039-8
doi: 10.1016/j.biologicals.2023.101701
pii:
doi:

Substances chimiques

Tetanus Toxoid 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

101701

Informations de copyright

Copyright © 2023. Published by Elsevier Ltd.

Auteurs

Rob Tierney (R)

Medicines and Healthcare products Regulatory Agency (MHRA), National Institute for Biological Standards and Control (NIBSC), South Mimms, Potters Bar, Hertfordshire, EN6 3QG, UK. Electronic address: rob.tierney@mhra.gov.uk.

Jason Hockley (J)

Medicines and Healthcare products Regulatory Agency (MHRA), National Institute for Biological Standards and Control (NIBSC), South Mimms, Potters Bar, Hertfordshire, EN6 3QG, UK.

Shalini Rajagopal (S)

Medicines and Healthcare products Regulatory Agency (MHRA), National Institute for Biological Standards and Control (NIBSC), South Mimms, Potters Bar, Hertfordshire, EN6 3QG, UK.

Paul Stickings (P)

Medicines and Healthcare products Regulatory Agency (MHRA), National Institute for Biological Standards and Control (NIBSC), South Mimms, Potters Bar, Hertfordshire, EN6 3QG, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH